Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with β-amyloid 1–42 in vitro
Section snippets
Acknowledgements
We are indebted to Dr R. Sandbrink for providing us post mortem brain tissue. We also thank J. Pilz (Institute of Medical Biometry and Informatics, Department of Medical Informatic, University of Heidelberg), who has done the statistical analysis. This work was supported by the University of Heidelberg (“Forschungsschwerpunkt Geriatrie”), Germany.
References (28)
- et al.
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
Neuropharmacology
(1994) - et al.
S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes
J. Biol. Chem.
(1996) - et al.
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
J. Neuroimmunol.
(1989) - et al.
Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain
Exp. Neurol.
(1989) - et al.
Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production
J. Biol. Chem
(1994) - et al.
Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes
Biochem. Biophys. Res. Comm.
(1996) - et al.
Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques
Exp. Neurol.
(1997) - et al.
Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains
Am. J. Pathol.
(1998) - et al.
Coinduction of inducible nitric oxide synthase and arginine recycling enzymes in cytokine-stimulated PC12 cells and high output production of nitric oxide
Brain Res. Mol. Brain Res.
(2000) - et al.
Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells
Brain Res.
(1999)
Immunologic NO-synthase: evaluation in severe AIDS dementia and induction by HIV-1 gp41
Science
Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NfkappaB-dependent mechanism
Proc. Natl. Acad. Sci. USA
Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines
Ann. N. Y. Acad. Sci.
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
Glia
Cited by (93)
Circulating arginine metabolites in Alzheimer's disease and vascular dementia: A systematic review and meta-analysis
2023, Ageing Research ReviewsNitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer's disease
2022, Free Radical Biology and MedicineComorbidity of osteoporosis and Alzheimer's disease: Is `AKT `-ing on cellular glucose uptake the missing link?
2022, Ageing Research ReviewsThe persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics
2021, International Review of NeurobiologyCitation Excerpt :As mentioned above, different adolescent binge ethanol exposures promotes persistent priming of microglia toward a proinflammatory phenotype. Further, several immune molecules that are persistently induced by alcohol exposure during adolescence are also involved in the pathology of AD; such as HMGB1, IL-1β, and TLR 4 (Combs, 2009; Fujita et al., 2016; Haas, Storch-Hagenlocher, Biessmann, & Wildemann, 2002; Takata et al., 2004; Wu, Zhang, Zhao, & Zhou, 2015). Two studies found that ethanol promoted amyloid pathology and inhibited microglial phagocytosis of Aβ (Huang et al., 2018; Kalinin et al., 2018).
The development and physiological and pathophysiological functions of resident macrophages and glial cells
2021, Advances in ImmunologyDevelopment of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease
2020, Biochemical PharmacologyCitation Excerpt :In this regard, it is possible that increased expression of iNOS and eNOS represents an inflammatory response triggered by Aβ deposition. This notion is supported by an in vitro study showing that synthetic Aβ1–42 peptide increased the expression of iNOS and, in turn, NO production in neuronal-glial cultures from rats [47]. Noticeably, a recent study suggested that the elevation of NOS activity could be a compensatory mechanism to restore the subtle synaptic changes occurring in pre-symptomatic AD, as shown with the 3xTg-AD transgenic mouse model [48].